PHILADELPHIA, PA--(Marketwire - Oct 22, 2012) - Invisible Sentinel Inc., a life sciences company that develops rapid diagnostics for the detection of foodborne pathogens, announced that Paul Touhey, Chief Executive Officer of Fujirebio Diagnostics, was elected to Invisible Sentinel's Board of Directors as an independent director.
Mr. Touhey is the accomplished CEO of Fujirebio Diagnostics, a leading edge cancer diagnostics company, and a Member of the Board of Directors for both Fujirebio Diagnostics and their parent company, Fujirebio Inc. Mr. Touhey brings over 25 years of experience in the diagnostic and life science industries to Invisible Sentinel, and has a remarkable track record of fostering the growth and success of the Companies with which he has worked.
"I'm proud to join Invisible Sentinel as a Director, and look forward to working with management to commercialize the Company's Veriflow™technology," said Mr. Touhey.
"Paul has had a very distinguished career and is one of the most highly regarded leaders in the business. We are privileged to add him to the Invisible Sentinel team and his guidance and expertise will be invaluable assets as we embark on commercializing our first-in-class diagnostic assays for the food industry," said Ben Pascal, co-founder and CEO of Invisible Sentinel.
Touhey began his career at Johnson & Johnson where he held a variety of positions with increasing levels of responsibility and management. In 1985, he joined Centocor where he served in the diagnostics division as Vice President of Operations until 1998 when the division was sold to Fujirebio. In 2010, Touhey was named CEO of the Year by the Pennsylvania Biotechnology Association.
Touhey serves on the Board of Directors of the University City Science Center and previously served on the Board of Directors for Orthovita, Inc., an orthobiologics company and Cernostics, Inc., a molecular cancer diagnostics company.
About Invisible Sentinel
Based in Philadelphia at the University City Science Center, Invisible Sentinel develops diagnostic technologies for a safer food supply. The Company's focus is on developing rapid diagnostics that quickly provide accurate information about the presence of harmful pathogens. The first in class patented technology, produced under good manufacturing practices, provides the same data as the USDA reference methods but minimizes the time, reduces the cost, and lowers the overhead associated with conventional diagnostics. The food industry is the first market that the Company is targeting, but its platform technology has the potential to provide valuable tools for additional industries including healthcare, veterinary, biodefense, and environmental testing, where rapid detection of target analytes from unrefined samples is critical. Uniquely designed for easy, practical use -- on-site and throughout the entire food distribution network -- Invisible Sentinel's proprietary diagnostic products promise to create a new standard for rigorous quality control.
About the University City Science Center
The University City Science Center accelerates technology commercialization, regional economic development, and the market availability of life-enhancing scientific breakthroughs by bringing together innovations, scientists, entrepreneurs, funding, laboratory facilities, and business services. Established in 1963 and headquartered in Philadelphia, PA, the Science Center was the first, and remains the largest, urban research park in the United States. Graduate organizations and current residents of the University City Science Center's Port business incubators have created more than 15,000 jobs that remain in the Greater Philadelphia region today and contribute more than $9 billion to the regional economy annually. For more information about the Science Center, go to www.sciencecenter.org.